In vitro Antiplasmodial and Cytotoxicity Evaluation of Ethanol Leaf Extract of Erythrina senegalensis DC
South Asian Research Journal of Natural Products,
This study evaluates in vitro antiplasmodial and cytotoxicity activity of an ornamental plant commonly employed in Northern part of Nigeria for curing malaria infection. Fresh mature leaves of Erythrina senegalensis were collected, air dried, ground, percolated in ethanol for two weeks and evaporated to dryness at room temperature. The dried ethanol crude extract was fractionated with pet-ether, chloroform, ethyl acetate and methanol in order of increasing polarity. These were screened for phytochemicals, in vitro antiplasmodial and cytotoxicity test using standard procedures. The results of the phytoconstituents revealed the presence of alkaloids, tannins, flavonoids and terpenoids which could be responsible for the medicinal properties of the extract. Ethanol crude extract, pet-ether and ethyl acetate fractions were discovered to be non-cytotoxic exhibiting LC50 > 1000 µg/ml respectively. Only methanol fraction showed slight toxicity with LC50 value of 630 µg/ml. The highest activity of the extract and its fractions against Artemia salina larvae was recorded at 1000 µg/ml dose whereas lowest larvicidal activities and lethalities occurred at 10 µg/ml dose. The ethanol extract and its fractions were significantly active against Plasmodium falciparum strain (K1) with percentage elimination of the parasites were in the range of 77% - 83% at 5000 µg/ml. Ethyl acetate (71%) and methanol fraction (71%) were found to be the most active fractions at the lowest concentration of 625 µg/ml. This finding justifies the usage of the plant in traditional medicine by traditional healers and local populace against malaria disease. The observed value for cytotoxicity assay of LC50>1000 µg/ml recorded for the ethanolic extract suggested that oral intake of the extract could be deemed safe and would not be lethal at low/moderate dose as lethality is directly proportional to dosage and oral consumption of the extract as over dosage could lead to lethality and subsequently, mortality over a long period of time due to bioaccumulation. The isolation of antiplasmodial compounds from the leaves of the plant is necessary as it could be a potential candidate for novel antimalarial drugs. Continuous utilization of the leaves as antimalarial and the wide range of its safety at low and moderate dosages further supports its use among the less privileged and vulnerable people in malaria endemic areas in lieu of existing expensive modern antimalarial drugs.
- Erythrina senegalensis DC
How to Cite
World Health Organization. Susceptibility of Plasmodium falciparum to antimalarial drugs: Report on global monitoring; 2004.
Kapoor LD, Singh A, Kapoor SL, Scrivastava SN. Survey of Indian medicinal plants for saponins, alkaloids and flavonoids. Lloydia. 1969;32:297–302.
Togola A, Austarheim I, Theïs A, Diallo D, Paulsen B. Ethnopharmacological uses of Erythrina senegalensis: A comparison of three areas in Mali, and a link between traditional knowledge and modern biological science. J Ethnobiol Ethnomed. 2008;4(1):6–17.
Kone WM, Solange KE, Dosso M. Assessing Sub-saharian Erythrina for efficacy: Traditional uses, biological activities and phytochemistry. Pak. J. Biological Sci. 2011;14(10):560-571.
Adamu HM, Abayeh OJ, Agho MO, Abdullahi AL, Uba A, et al. An ethnobotanical survey of Bauchi State herbal plants and their antimicrobial activity. J Ethnopharmacol. 2005;99:1-4.
Saidu K, Onah J, Orisadipe A, Olisola A, Wambebe C, Gammel K. Antiplasmodial and analgesic and anti-inflammatory activities of aqueous extract of stem bark of Erythrina senegaleusis. J Ethno-pharmacol. 2000;71(1):273–280.
Atindehou KK, Schmid C, Brun R, Koné MW, Traore D. Antitrypanosomal and anti-plasmodial activity of medicinal plants from Côte d’Ivoire. J Ethnopharmacol. 2004;90: 221–227.
Yenesew A, Induli M, Derese S, Midiwo JO, Heydenreich M, et al. Anti-plasmodial flavonoids from the stem bark of Erythrina abyssinica. Phytochemistry. 2004;65:3029-3032.
Khaomek P, Ichino C, Ishiyama A, Sekiguchi H, Namatame M. In vitro antimalarial activity of prenylated flavonoids from Erythrina fusca. J. Nat. Med. 2008;62:217-220.
Innok P, Rukachaisirikul T, Suksamrarn A. Flavanoids and pterocarpans from the bark of Erythrina fusca. Chem. Pharm. Bull. 2009;57:993-996.
Herlina T, Supratman U, Soedjanaatmadja MS, Subarnas A, Sutardjo S, Abdullah NR, Hayashi H. Anti-malarial compound from the stem bark of Erythrina variegata. Indo J Chem. 2009;9(2):308-311.
Innok P, Rukachaisirikul T, Phongpaichit S, Suksamrarn A. Fuscacarpans A–C, New pterocarpans from the stems of Erythrina fusca. Fitoterapia. 2010;81(6): 518-523.
Fatope MO, Adoum OA. Bioactivity of some savanna plants in the brine shrimp lethality test and In-vitro antimicrobial assay. Int. J. Pharmacognosy. 1993;35(5): 334-337.
Trease GE, Evans WC. Textbook of pharmacognosy (13th Edition). ELBS Baillers Tindal, London. 1989;378-386.
Harborne JB. Phytochemical methods: A guide to modern technique of plant analysis, 3rd Eds. Chapman and Hall Int. Eds, New York; 1998.
Kokate CK. Practical pharmacognosy, 4th Eds. Vallabh Prakasan, Delhi, India. 1994;107-111.
Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: A general bioassay for active plant constituents. Planta Medica. 1982;45:31-34.
Adoum OA. Determination of toxicity effect of some savannah plants. Africa. Journal of Infectious Diseases. 1997;167:932-937.
World Malaria Report. Information available to WHO and UNICEF at the end of 2004; 2005.
Dacie JV, Lewis SM, Eds. Practical haematology. Fourth Edition, Black Well Publisher, USA. 1968;65-66.
Hanne IZ, Dan S, Jette C, Lars H, Henry H, Jorzy WJ. In-vitro Plasmodium falciparum sensitivity assay. Antimicrobial Agent and Chemotheraphy. 2002;42(6): 1441-1446.
Trager W. Cultivation of malaria parasites. Pakistan Journal of Biological Science. 1982;14(10):560–571.
Mukhtar MD, Bashir AAH. Comparative In-vitro studies on antiplasmodial activity of some Nigeria and Foreign brands of Chloroquine oral formulation marketed in Kano. Africa Journal of Biotechnology. 2006;5(24):2464-2468.
Donfack JH, Njayou FN, Rodrigue TK, Chuisseu DDP, Tchana NA, Vita Finzi P, Tchouanguep MF, Ngadjui TB, Moundipa FP. Study of a hepatoprotective and antioxidant fraction from Erythrina senegalensis stem bark extract: In vitro and In vivo. Pharmacology Online. 2008;1: 120-130.
Doughari JH. Evaluation of antimicrobial potentials of stem bark extracts of Erythrina senegalensis DC. Afr. J. Microbiol. Res. 2010;4(17):1836-1841.
Oh WK, Lee HS, Ahn SC, Ahn JS, Mbafor JT, et al. Prenylated isoflavonoids from Erythrina senegalensis. Phytochemistry. 1999;51:1147-1150.
Wandji J, Fomum ZT, Tillequin F, Baudouin G, Koch M. Expoxyisoflavones from Eryhtrina senegalensis. Phyto-chemistry. 1994;35:1573- 1577.
Mann A, Buso A, Chifford LC. Anntifungal properties of Angogeissusleio carpus and Terminalia icenniodes. Tanzania Journal of Health Research. 2008;10:34-38.
Wandji J, Awanchiri SS, Fomum ZT, Tillequin F, Libot F. Isoflavones and alkaloids from the stem bark and seeds of Erythrina senegalensis. Phytochemistry. 1995;39:677-681.
Atsamo AD, Nguelefack TB, Datte JY, Kamanyi A. Acute and subchronic oral toxicity assessment of the aqueous extract from the stem bark of Erythrina senegalensis DC (Fabaceae) in Rodents. J. Ethnopharmacol. 2011;134:697-702.
Wilson O, Henry LB, Joseph A, Hakeino P, Husseini B. Effects of Erythrina senegalensis aqueous leaf extract in rats. American Journal of Research Communication. 2014;2(4):179-185.
Nnama TN, Asomugha AL, Asomugha RN, Umeasalugo KE, Mgbemena IO. Phytochemical analysis and acute toxicological study of Erythrina senegalensis ethanolic leaf extract in albino wistar rats. Anat Physiol. 2017;7: 248.
Tepongning RN, Yerbanga SR, Dori GU, Lucantoni L, Lupidi G, Habluetzel A. In vivo efficacy and toxicity studies on Erythrina senegalensis and Khaya ivorensis used as herbal remedies for malaria prevention in Cameroon. Eur J Med Plants. 2013;3(3): 454–464.
Joanne B, Michel F, Joelle Q. Antimalarial compounds isolated from plants used in herbal medicine. J. International Medicine. 2009;61:1401–1433.
Bioland BP, Ethling M. Malarial treatment policy in the face of drug resistances, tropical medicine and parasitology; 2001.
Deloron P, Lepers JP, Verdier F, Chougnet C, Remananmirija JA, Andriamangatiana-Rason MD, Coulanges P, Jaureguiberry G. Efficacy of a 3-day oral regimen of a Quinine-quinidine-cinchonine Association (QuinimaxO) for treatment of falciparum malaria in Madagascar. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1989;83:751-754.
Qinghaosu Antimalaria Coordinating Research Group. Antimalarial studies on Qinghaosu. Chinese Medical Journal. 1979;12:811-816.
Sanjib M, Mishra SK, Satpathy SK, Sanghamitra D, Jayakrishna P. Alpha, beta-arteether for the treatment of complicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1997;91(3):328-330.
François N, Nicholas JW. Defining and defeating the intolerable burden of malaria III: Progress and perspectives: Artemisinin-based combination treatment of falciparum malaria. American Journal of Tropical Medicine and Hygiene. 2007;77(6).
World Health Organization. Artemisinin resistance and artemisinin-based combination therapy efficacy. Global Malaria Programme (Status Report); 2018.
Osuntokun TO, Ajayi AO, Olorunnipa TA, Thonda OA, Taiwo OV. Phytochemical screening and antimicrobial properties of partially purified ethyl acetate extracts of Erythrina senegalensis leaf and bark against selected clinical isolates. J Med Plants Stud. 2016;4(3):259– 269.
Abstract View: 495 times
PDF Download: 383 times